pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›LIDOCAINE
drug · small molecule
save

LIDOCAINE

Marketedupdated 5mo ago
by MEDRx Co Ltd🔗 ChEMBL
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval330 co-mentions · 137 sources
  • druglidocaine SR278 co-mentions · 174 sources
  • drugLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE238 co-mentions · 81 sources
  • drugLIDOCAINE HYDROCHLORIDE236 co-mentions · 140 sources
  • drugAKTEN228 co-mentions · 139 sources
  • drugLinisol223 co-mentions · 139 sources
  • drugLaryng-O-Jet223 co-mentions · 139 sources
  • drugLIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%223 co-mentions · 139 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 21 approved and 110 investigational indications.

targets

Sodium channel alpha subunit

all catalysts(5)

approval · 1
Feb 9, 2026
approval
8mo ago
LIDOCAINE — FDA approval
LIDOCAINE
→
phase 2 completion · 3
Apr 27, 2026
phase 2 completion
6mo ago
Sustained Therapeutics Inc — lidocaine SR (Phase II Trial Completion)
LIDOCAINE
→
Apr 30, 2026
phase 2 completion
5mo ago
Huadong Hospital Affiliated to Fudan University — lidocaine (Phase II Trial Completion)
LIDOCAINE
→
Apr 30, 2026
phase 2 completion
5mo ago
Cairo University — lidocaine (Phase II Trial Completion)
LIDOCAINE
→
phase 3 completion · 1
Apr 25, 2026
phase 3 completion
6mo ago
Ain Shams University — lidocaine (Phase III Trial Completion)
LIDOCAINE
→

Trials studying LIDOCAINE

  • phase3A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participantscompletedn=252
  • phase4Restoring Facial Volume After GLP-1 Weight Loss With Radiesserecruitingn=48
  • phase3Study to Assess Adverse Events and How Effective NOA LIFT is Compared to JUVÉDERM VOLIFT With Lidocaine for the Correction of Nasolabial Folds in Adultsrecruitingn=288
  • phase3Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesianot yet recruitingn=76
  • N/AEfficacy and Safety of Rejuviel V in the Correction of Midface Volume Deficitcompletedn=89
  • phase1Bioequivalence Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjectscompletedn=40
  • phase4Workflow Optimization During Pulse Field Ablation for Atrial Fibrillationnot yet recruitingn=60
  • phase3Saypha® VOLUME Lidocaine for Midface Augmentationcompletedn=562

Patent cliff

source: FDA Orange Book
first barrier falls
Sep 24, 2028
~2.0 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (8)

  • May 10, 2031formulationUS 107656404.6y
  • May 10, 2031formulationUS 107657494.6y
  • May 10, 2031formulationUS 112786234.6y
  • May 10, 2031formulationUS 117864554.6y
  • May 10, 2031method-of-use (U-2267)US 117937664.6y
  • May 10, 2031formulationUS 92831744.6y
  • May 10, 2031formulationUS 99252644.6y
  • May 10, 2031formulationUS 99314034.6y

FDA exclusivities (1)

  • Sep 24, 2028NPNP2.0y

News(10)

  • Convenience Kit Correction: Becton Dickinson Issues Correction for Kits and Procedure Trays Containing Recalled Sodium Chloride Ampules
    BD is correcting convenience kits and procedural trays containing recalled Huons Co. sodium chloride ampules
    fda_medwatch · 15d ago
  • Convenience Kit Correction: AVID Medical Issues Correction for Kits Containing Huons Sodium Chloride Ampules
    AVID Medical is correcting convenience kits containing recalled Huons Co. sodium chloride ampules.
    fda_medwatch · 18d ago
  • Sodium Chloride Flush Recall: Spectra Medical Removes Sodium Chloride Injection USP Ampules
    Spectra Medical Devices is removing Sodium Chloride Flush products that were manufactured by Huons Co,. Ltd.
    fda_medwatch · 21d ago
  • Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules
    Medical Action Industries is correcting epidural kits containing recalled Huons Co. sodium chloride ampules.
    fda_medwatch · 29d ago
  • Early Alert: Convenience Kit Issue from AVID Medical
    AVID Medical is correcting convenience kits containing recalled Huons Co. sodium chloride ampules.
    fda_medwatch · 1mo ago
  • Early Alert: Epidural Kit Issue from Medical Action Industries
    Medical Action Industries is correcting epidural kits containing recalled Huons Co. sodium chloride ampules.
    fda_medwatch · 1mo ago
  • Early Alert: Convenience Kit Issue from Becton Dickinson
    BD is correcting convenience kits and procedural trays containing recalled Huons Co. sodium chloride ampules
    fda_medwatch · 1mo ago
  • Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection
    Medline is correcting affected convenience kits by removing recalled Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection components from affected convenience kits.
    fda_medwatch · 2mo ago
  • Convenience Kit Correction: Argon Medical Issues Correction for Convenience Kits Containing Spectra Medical Device Lidocaine Ampules
    Argon Medical is correcting affected convenience kits by removing included Spectra Medical Devices Lidocaine Ampules.
    fda_medwatch · 2mo ago
  • Convenience Kit Correction: Arrow International Issues Correction for Convenience Kits Containing Recalled Huons Lidocaine and Bupivacaine and Saline
    Saline, Lidocaine and Bupivacaine from affected convenience kits should not be used.
    fda_medwatch · 2mo ago
view all news mentions →
brand
LIDOCAINE
trade names
Alphacaine, Dentipatch, Lidocaine, Lidocaine component of emla, Lidocaine component of fortacin, Lidocaine component of lanabiotic
generic
LIDOCAINE
MOA
Sodium channel alpha subunit blocker
indication
Postherpetic Neuralgia
phase
marketed
Data sources
openFDA · ClinicalTrials.gov · OpenTargets
last refreshed 3h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?